|
π
|
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
13 auth.
M. Gertz,
R. Comenzo,
R. Falk,
J. Fermand,
B. Hazenberg,
P. Hawkins,
G. Merlini,
P. Moreau,
P. Ronco,
V. Sanchorawala,
...
O. Sezer,
A. Solomon,
G. Grateau
|
10 |
2005 |
10
π
|
|
π
|
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes.
8 auth.
H. Moshage,
H. Roelofs,
J. F. Pelt,
B. Hazenberg,
M. V. Leeuwen,
P. Limburg,
...
L. Aarden,
S. Yap
|
8 |
1988 |
8
π
|
|
π
|
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
11 auth.
C. Maas,
J. Govers-Riemslag,
B. Bouma,
Bettina Schiks,
B. Hazenberg,
H. Lokhorst,
...
P. HammarstrΓΆm,
H. ten Cate,
P. D. de Groot,
B. Bouma,
M. Gebbink
|
8 |
2008 |
8
π
|
|
π
|
Eprodisate for the treatment of renal disease in AA amyloidosis.
15 auth.
L. Dember,
P. Hawkins,
B. Hazenberg,
P. Gorevic,
G. Merlini,
I. ButrimienΔ,
A. Livneh,
O. Lesnyak,
X. PuΓ©chal,
H. Lachmann,
...
L. Obici,
R. Balshaw,
D. Garceau,
W. Hauck,
M. Skinner
|
7 |
2007 |
7
π
|
|
π
|
First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy
9 auth.
D. Adams,
O. Suhr,
E. Hund,
L. Obici,
I. Tournev,
J. Campistol,
...
M. Slama,
B. Hazenberg,
T. Coelho
|
7 |
2016 |
7
π
|
|
π
|
Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acuteβphase proteins during the treatment of severe sepsis in humans
8 auth.
A. Dofferhoff,
V. Bom,
H. D. de Vries-Hospers,
J. V. Ingen,
J. Meer,
B. Hazenberg,
...
P. O. Mulder,
J. Weits
|
7 |
1992 |
7
π
|
|
π¦
|
Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
8 auth.
B. Hazenberg,
M. V. van Rijswijk,
D. Piers,
M. L. Lub-de Hooge,
E. Vellenga,
E. Haagsma,
...
P. Hawkins,
P. L. Jager
|
7 |
2006 |
7
π¦
|
|
π’
|
Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
9 auth.
A. Glaudemans,
R. V. van Rheenen,
M. P. van den Berg,
W. Noordzij,
M. Koole,
H. Blokzijl,
...
R. Dierckx,
R. Slart,
B. Hazenberg
|
7 |
2014 |
7
π’
|
|
π¦
|
Amyloidosis: a clinical overview.
B. Hazenberg
|
7 |
2013 |
7
π¦
|
|
π
|
Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
8 auth.
M. D. de Vries,
I. C. van Eijk,
I. E. van der Horst-Bruinsma,
M. Peters,
M. Nurmohamed,
B. Dijkmans,
...
B. Hazenberg,
G. Wolbink
|
6 |
2009 |
6
π
|
|
π’
|
Laryngeal Amyloidosis: Localized versus Systemic Disease and Update on Diagnosis and Therapy
H. Bartels,
F. Dikkers,
H. Lokhorst,
J. E. van der Wal,
B. Hazenberg
|
6 |
2004 |
6
π’
|
